Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 20:38:10 UTC
Update Date2021-09-26 23:16:03 UTC
HMDB IDHMDB0258851
Secondary Accession NumbersNone
Metabolite Identification
Common NameTesevatinib
DescriptionTesevatinib belongs to the class of organic compounds known as quinazolinamines. These are heterocyclic aromatic compounds containing a quianazoline moiety substituted by one or more amine groups. Based on a literature review a small amount of articles have been published on Tesevatinib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Tesevatinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Tesevatinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
SynonymsNot Available
Chemical FormulaC24H25Cl2FN4O2
Average Molecular Weight491.39
Monoisotopic Molecular Weight490.1338596
IUPAC NameN-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-({2-methyl-octahydrocyclopenta[c]pyrrol-5-yl}methoxy)quinazolin-4-amine
Traditional NameN-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-({2-methyl-hexahydro-1H-cyclopenta[c]pyrrol-5-yl}methoxy)quinazolin-4-amine
CAS Registry NumberNot Available
SMILES
COC1=C(OCC2CC3CN(C)CC3C2)C=C2N=CN=C(NC3=C(F)C(Cl)=C(Cl)C=C3)C2=C1
InChI Identifier
InChI=1S/C24H25Cl2FN4O2/c1-31-9-14-5-13(6-15(14)10-31)11-33-21-8-19-16(7-20(21)32-2)24(29-12-28-19)30-18-4-3-17(25)22(26)23(18)27/h3-4,7-8,12-15H,5-6,9-11H2,1-2H3,(H,28,29,30)
InChI KeyHVXKQKFEHMGHSL-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as quinazolinamines. These are heterocyclic aromatic compounds containing a quianazoline moiety substituted by one or more amine groups.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassDiazanaphthalenes
Sub ClassBenzodiazines
Direct ParentQuinazolinamines
Alternative Parents
Substituents
  • Quinazolinamine
  • Aniline or substituted anilines
  • 1,2-dichlorobenzene
  • Anisole
  • Halobenzene
  • Fluorobenzene
  • Chlorobenzene
  • Aminopyrimidine
  • Alkyl aryl ether
  • Imidolactam
  • Benzenoid
  • N-alkylpyrrolidine
  • Pyrimidine
  • Monocyclic benzene moiety
  • Aryl halide
  • Aryl fluoride
  • Aryl chloride
  • Heteroaromatic compound
  • Pyrrolidine
  • Tertiary aliphatic amine
  • Tertiary amine
  • Azacycle
  • Secondary amine
  • Ether
  • Organic nitrogen compound
  • Organic oxygen compound
  • Organopnictogen compound
  • Hydrocarbon derivative
  • Organooxygen compound
  • Organonitrogen compound
  • Organofluoride
  • Organochloride
  • Organohalogen compound
  • Amine
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP5.51ALOGPS
logP5.25ChemAxon
logS-5.2ALOGPS
pKa (Strongest Acidic)14.01ChemAxon
pKa (Strongest Basic)9.84ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area59.51 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity127.76 m³·mol⁻¹ChemAxon
Polarizability50.9 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityYesChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+210.2530932474
DeepCCS[M-H]-207.89230932474
DeepCCS[M-2H]-240.81230932474
DeepCCS[M+Na]+216.34430932474

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.4.37 minutes32390414
Predicted by Siyang on May 30, 202211.856 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20222.39 minutes32390414
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid2040.2 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid191.8 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid177.5 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid171.3 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid138.1 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid484.9 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid460.0 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)375.7 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid873.3 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid389.5 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1456.2 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid285.3 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid305.6 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate256.4 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA136.5 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water17.3 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
TesevatinibCOC1=C(OCC2CC3CN(C)CC3C2)C=C2N=CN=C(NC3=C(F)C(Cl)=C(Cl)C=C3)C2=C14933.9Standard polar33892256
TesevatinibCOC1=C(OCC2CC3CN(C)CC3C2)C=C2N=CN=C(NC3=C(F)C(Cl)=C(Cl)C=C3)C2=C13591.7Standard non polar33892256
TesevatinibCOC1=C(OCC2CC3CN(C)CC3C2)C=C2N=CN=C(NC3=C(F)C(Cl)=C(Cl)C=C3)C2=C14053.8Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Tesevatinib,1TMS,isomer #1COC1=CC2=C(N(C3=CC=C(Cl)C(Cl)=C3F)[Si](C)(C)C)N=CN=C2C=C1OCC1CC2CN(C)CC2C13723.7Semi standard non polar33892256
Tesevatinib,1TMS,isomer #1COC1=CC2=C(N(C3=CC=C(Cl)C(Cl)=C3F)[Si](C)(C)C)N=CN=C2C=C1OCC1CC2CN(C)CC2C13622.8Standard non polar33892256
Tesevatinib,1TMS,isomer #1COC1=CC2=C(N(C3=CC=C(Cl)C(Cl)=C3F)[Si](C)(C)C)N=CN=C2C=C1OCC1CC2CN(C)CC2C14926.8Standard polar33892256
Tesevatinib,1TBDMS,isomer #1COC1=CC2=C(N(C3=CC=C(Cl)C(Cl)=C3F)[Si](C)(C)C(C)(C)C)N=CN=C2C=C1OCC1CC2CN(C)CC2C13896.1Semi standard non polar33892256
Tesevatinib,1TBDMS,isomer #1COC1=CC2=C(N(C3=CC=C(Cl)C(Cl)=C3F)[Si](C)(C)C(C)(C)C)N=CN=C2C=C1OCC1CC2CN(C)CC2C13820.8Standard non polar33892256
Tesevatinib,1TBDMS,isomer #1COC1=CC2=C(N(C3=CC=C(Cl)C(Cl)=C3F)[Si](C)(C)C(C)(C)C)N=CN=C2C=C1OCC1CC2CN(C)CC2C14941.7Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Tesevatinib GC-MS (Non-derivatized) - 70eV, Positivesplash10-000t-6312900000-c1603aa57948702803302021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Tesevatinib GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID37994857
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkTesevatinib
METLIN IDNot Available
PubChem Compound25051518
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]